Weekly Injectable Treatment May Transform Parkinson’s Disease Management: Study
Parkinson’s disease, the second most common neurodegenerative disorder after Alzheimer’s, affects over 10 million people globally, with symptoms typically emerging after age 50.
Patients often rely on multiple daily tablets to manage symptoms like tremors, stiffness, and balance issues.
Australian scientists have developed a potential weekly injectable treatment, which could significantly improve the quality of life for those with Parkinson’s if proven safe and effective.
- The treatment involves an in-situ forming implant system designed to provide sustained delivery of levodopa and carbidopa.
- These two drugs are standardly used to treat Parkinson’s disease symptoms.
No specific quote available in the text.
A recent study published in Drug Delivery and Translational Research, led by Professor Sanjay Garg from the Centre for Pharmaceutical Innovation, University of South Australia, explored the development of this long-acting therapy.
Author’s summary: Scientists develop potential weekly injectable treatment for Parkinson’s.
More News
- Jensen Ackles back on 'Tracker' 3.2 to amp up the suspense
- Why Experienced Lawyers Matter in a Personal Injury Case | NorthPennNow
- READY, FIRE, AIM: Fly Me to the Moon – Pagosa Daily Post News Events & Video for Pagosa Springs Colorado
- US contractor agrees to deep-water pact with Shell
- Leptin neural circuit restores balance after anxiety upsets it
- Novartis to Acquire Avidity for $12B, Bolstering Neuroscience Pipeline
- Meet the AI Disruptors 60: The Startups Defining AI’s Future | TechCrunch
- The Founding of New York - Historic UK
- Organon CEO stands down amid contraceptive sales malpractice probe - Pharmaceutical Technology
- Why Hiring a Fishers Personal Injury Lawyer Is Key After a Car Accident, Slip, or Dog Bite | NorthPennNow